Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 161

1.

Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.

Lemoinne S, Kemgang A, Ben Belkacem K, Straube M, Jegou S, Corpechot C; Saint-Antoine IBD Network, Chazouillères O, Housset C, Sokol H.

Gut. 2019 Apr 19. pii: gutjnl-2018-317791. doi: 10.1136/gutjnl-2018-317791. [Epub ahead of print]

PMID:
31003979
2.

Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis.

Lemoinne S, Cazzagon N, El Mouhadi S, Trivedi PJ, Dohan A, Kemgang A, Ben Belkacem K, Housset C, Chretien Y, Corpechot C, Hirschfield G, Floreani A, Motta R, Gallix B, Barkun A, Barkun J, Chazouillères O, Arrivé L.

Clin Gastroenterol Hepatol. 2019 Mar 14. pii: S1542-3565(19)30277-0. doi: 10.1016/j.cgh.2019.03.013. [Epub ahead of print]

PMID:
30880273
3.

Editorial: simplifying screening for primary liver cancer - do the LCR1 and LCR2 tests hold the key? Authors' reply.

Poynard T, Deckmyn O, Housset C; HECAM-FibroFrance Group.

Aliment Pharmacol Ther. 2019 Mar;49(5):613-614. doi: 10.1111/apt.15135. No abstract available.

PMID:
30746767
4.

Editorial: Genetics of cholangiopathies.

Barbu V, Housset C.

Curr Opin Gastroenterol. 2019 Mar;35(2):63-64. doi: 10.1097/MOG.0000000000000510. No abstract available.

PMID:
30624246
5.

Modifier genes in cystic fibrosis-related liver disease.

Debray D, Corvol H, Housset C.

Curr Opin Gastroenterol. 2019 Mar;35(2):88-92. doi: 10.1097/MOG.0000000000000508.

PMID:
30585791
6.

LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.

Poynard T, Peta V, Deckmyn O, Munteanu M, Moussalli J, Ngo Y, Rudler M, Lebray P, Pais R, Bonyhay L, Charlotte F, Thibault V, Fartoux L, Lucidarme O, Eyraud D, Scatton O, Savier E, Valantin MA, Ngo A, Drane F, Rosmorduc O, Imbert-Bismut F, Housset C, Thabut D, Ratziu V; HECAM-FibroFrance Group.

Aliment Pharmacol Ther. 2019 Feb;49(3):308-320. doi: 10.1111/apt.15082. Epub 2018 Dec 19.

PMID:
30569507
7.

Diet-Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice.

Debray D, El Mourabit H, Merabtene F, Brot L, Ulveling D, Chrétien Y, Rainteau D, Moszer I, Wendum D, Sokol H, Housset C.

Hepatol Commun. 2018 Oct 10;2(12):1533-1549. doi: 10.1002/hep4.1266. eCollection 2018 Dec.

8.

Hepatic encephalopathy: Another brick in the wall.

Weiss N, Housset C, Thabut D.

J Hepatol. 2019 Jan;70(1):8-10. doi: 10.1016/j.jhep.2018.10.016. Epub 2018 Nov 7. No abstract available.

PMID:
30414737
9.

Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.

Munteanu M, Pais R, Peta V, Deckmyn O, Moussalli J, Ngo Y, Rudler M, Lebray P, Charlotte F, Thibault V, Lucidarme O, Ngo A, Imbert-Bismut F, Housset C, Thabut D, Ratziu V, Poynard T; FibroFrance Group.

Aliment Pharmacol Ther. 2018 Nov;48(10):1117-1127. doi: 10.1111/apt.14990. Epub 2018 Oct 17.

10.

Endoplasmic reticulum stress induces inverse regulations of major functions in portal myofibroblasts during liver fibrosis progression.

Loeuillard E, El Mourabit H, Lei L, Lemoinne S, Housset C, Cadoret A.

Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3688-3696. doi: 10.1016/j.bbadis.2018.10.008. Epub 2018 Oct 4.

PMID:
30292633
11.

Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.

Lemoinne S, Pares A, Reig A, Ben Belkacem K, Kemgang Fankem AD, Gaouar F, Poupon R, Housset C, Corpechot C, Chazouillères O.

Clin Res Hepatol Gastroenterol. 2018 Dec;42(6):521-528. doi: 10.1016/j.clinre.2018.06.009. Epub 2018 Aug 9.

12.

The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma.

Vaquero J, Lobe C, Tahraoui S, Clapéron A, Mergey M, Merabtene F, Wendum D, Coulouarn C, Housset C, Desbois-Mouthon C, Praz F, Fouassier L.

Clin Cancer Res. 2018 Sep 1;24(17):4282-4296. doi: 10.1158/1078-0432.CCR-17-3725. Epub 2018 May 1.

PMID:
29716918
13.

Gallstone disease, towards a better understanding and clinical practice.

Housset C.

Curr Opin Gastroenterol. 2018 Mar;34(2):57-58. doi: 10.1097/MOG.0000000000000425. No abstract available.

PMID:
29266010
14.

Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives.

Debray D, Narkewicz MR, Bodewes FAJA, Colombo C, Housset C, de Jonge HR, Jonker JW, Kelly DA, Ling SC, Poynard T, Sogni P, Trauner M, Witters P, Baumann U, Wilschanski M, Verkade HJ.

J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):443-448. doi: 10.1097/MPG.0000000000001676.

PMID:
28753176
15.

Comparison of in silico prediction and experimental assessment of ABCB4 variants identified in patients with biliary diseases.

Khabou B, Durand-Schneider AM, Delaunay JL, Aït-Slimane T, Barbu V, Fakhfakh F, Housset C, Maurice M.

Int J Biochem Cell Biol. 2017 Aug;89:101-109. doi: 10.1016/j.biocel.2017.05.028. Epub 2017 Jun 3.

PMID:
28587926
16.

Expression patterns of nuclear receptors in parenchymal and non-parenchymal mouse liver cells and their modulation in cholestasis.

Gonzalez-Sanchez E, Firrincieli D, Housset C, Chignard N.

Biochim Biophys Acta Mol Basis Dis. 2017 Jul;1863(7):1699-1708. doi: 10.1016/j.bbadis.2017.04.004. Epub 2017 Apr 6.

17.

Targeted pharmacotherapies for defective ABC transporters.

Vauthier V, Housset C, Falguières T.

Biochem Pharmacol. 2017 Jul 15;136:1-11. doi: 10.1016/j.bcp.2017.02.020. Epub 2017 Feb 27. Review.

PMID:
28245962
18.

Updates on primary sclerosing cholangitis.

Housset C.

Curr Opin Gastroenterol. 2017 Mar;33(2):69-70. doi: 10.1097/MOG.0000000000000342. No abstract available.

PMID:
28079751
19.

Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770).

Delaunay JL, Bruneau A, Hoffmann B, Durand-Schneider AM, Barbu V, Jacquemin E, Maurice M, Housset C, Callebaut I, Aït-Slimane T.

Hepatology. 2017 Feb;65(2):560-570. doi: 10.1002/hep.28929. Epub 2016 Dec 24.

PMID:
28012258
20.

Functions of the Gallbladder.

Housset C, Chrétien Y, Debray D, Chignard N.

Compr Physiol. 2016 Jun 13;6(3):1549-77. doi: 10.1002/cphy.c150050. Review.

PMID:
27347902

Supplemental Content

Loading ...
Support Center